Restenosis

Login

-> Clinical Trials

-> Abstracts

4/18/2006

Persistent Inhibition of Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation
Muzaffer Degertekin, Patrick W. Serruys, David P. Foley, Kengo Tanabe, Evelyn Regar, Jeroen Vos, Peter C. Smits, Wim J. van der Giessen, Marcel van den Brand, Pim de Feyter, Jeffrey J. Popma

-> Slide Presentations

4/20/2006	Cellular Radiosensitivity and the Response of Somatic Cells Eric J. Hall
4/19/2006	Repeat Vascular Brachytherapy for Recurrent In-Stent Restenosis Eric Eeckhout
4/19/2006	Local Delivery I: Drugs Steven R Bailey MD
4/19/2006	Stent Based Cytostatic Immunosuppressive Therapies Andrew J. Carter D.O.
4/19/2006	Pharmacologic Therapy for Restenosis: Is There Hope? Holmes
4/19/2006	Fibrinogen: The Central Molecule in Stent Restenosis Julio C Palmaz, MD
4/19/2006	The Ideal Animal Model for Restenosis Renu Virmani, MD
4/19/2006	Clinical and Angiographic Outcomes After Use of Sr-90 Jeffrey J. Popma
4/19/2006	Restenosis Holmes
4/19/2006	TAXUS Paclitaxel Eluting Stent Program - From Bench to Bedside Stephen G. Ellis, MD